Biotechnology - Pharmaceutical, Vaccines


Current filters:


Popular Filters

GlaxoSmithKline's cancer drug candidate fails endpoint in melanoma


UK pharma giant GlaxoSmithKline (LSE: GSK) and partner US biotech firm Agenus (Nasdaq: AGEN) this morning…


Negative FDA news for AVEO's tivozanib and Dynavax' hep B vaccine


US biotech firm AVEO Oncology (Nasdaq: AVEO) says that it has received a complete response letter from…

Anti-viralsAstellas PharmaAVEO OncologyBiotechnologyDynavax TechnologiesHeplisavNorth AmericaOncologyPharmaceuticalRegulationtivozanibVaccines

Regulatory briefs: Sanofi's Fluzone; Roche' RoActemra; Takeda's Rienso


French pharma major Sanofi (Euronext: SAN) today (June 10) announced that the US Food and Drug Administration…

Anti-Arthritics/RheumaticsBiotechnologyPharmaceuticalRegulationRocheSanofiTakeda PharmaceuticalsVaccines

GSK to boost vaccines business with 250 million-euro buy of Swiss firm Okairos


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday (May 29) revealed that it has acquired Swiss closely-held…

BiotechnologyGlaxoSmithKlineMergers & AcquisitionsOkairosPharmaceuticalVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst


While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Generex highlights pipeline potential of Antigen Express subsidiary


Canada-based Generex Biotechnology (OTC Bulletin Board: GNBT) last week provided an overview of the current…

AE37Anti-viralsAntigen ExpressBiotechnologyGenerex BiotechnologyOncologyPharmaceuticalResearchVaccines

Animal tests show CEL-SCI's novel vaccine can prevent and treat breast cancer


USA-based drug developer CEL-SCI Corp (NYSE MKT: CVM) says that its longstanding collaboration with Northeast…

BiotechnologyCEL-SCI CorpOncologyPharmaceuticalResearchVaccines

FDA approves Protein Sciences egg-free flu vaccine Flublok; and Octapharma's Octaplas


The US Food and Drug Administration revealed it has approved privately-held US biotech firm Protein Sciences…

Anti-viralsBiotechnologyFlublokMergers & AcquisitionsNorth AmericaOctapharmaOctaplasPanblokPharmaceuticalProtein Sciences CorpRegulationVaccines

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen


Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer…

BiotechnologyDekavilGlycoVaxynInflammatory diseasesJanssenJohnson & JohnsonLicensingPfizerPharmaceuticalPhilogenVaccines

Health Canada approves Vertex' Kalydeco; and Sanofi Pasteur's Menactra


Vertex Pharmaceuticals (Nasdaq: VRTX) says that Health Canada has approved Kalydeco (ivacaftor), the…

BiotechnologyKalydecoMenactraNorth AmericaPharmaceuticalRare diseasesRegulationSanofiSanofi PasteurVaccinesVertex

Sanofi inks up to $900 million allergy pact with Selecta Biosciences


US clinical-stage biopharma company Selecta Biosciences revealed this morning that it has entered into…

BiotechnologyImmunologicalsLicensingPharmaceuticalResearchSanofiSelecta BiosciencesVaccines

Positive CHMP recommendations for Sanofi and Novartis, but not for Celgene


There was a batch of good news for two pharma companies and a negative opinion for one last Friday coming…


News briefs from Sanofi, Biogen/SOBI and Novartis


French drug major Sanofi (Euronext: SAN) and subsidiary Genzyme have reported results from pivotal studies…

AgrippalBiogen IdecBiotechnologyFluadLemtradaNeurologicalNovartisPharmaceuticalRegulationResearchSanofiSwedish Orphan BiovitrumVaccines

News briefs from Threshold, Merck KGaA and GSK


US biotech firm Threshold Pharmaceuticals (Nasdaq: THLD) said yesterday that data from a Phase IIb trial…

BiotechnologyErbituxEuropeGlaxoSmithKlineMerck KGaAMerck SeronoOncologyPharmaceuticalRegulationResearchSynflorixTH-302Threshold PharmaceuticalsVaccines

Biological launches Japanese Encephalitis vaccine JEEV in India


Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

European vaccines market forecast to grow to $12.05 billion in 2018


As vaccine manufacturers increasingly tend to leverage on novel technologies, and potential late-stage…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalProductionVaccines

Crucell and Scripps Research discover broad-spectrum antibodies against influenza B


In what is described as a landmark discovery, researchers from Crucell Holland, which became wholly-owned…

Anti-viralsBiotechnologyCrucellJohnson & JohnsonPharmaceuticalResearchVaccines

Bilthoven Biologicals acquired by Serum Institute of India


Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

PhRMA firms have nearly 300 therapeutic vaccines in development


US research-based biopharmaceutical companies are developing nearly 300 vaccines for the prevention and…

BiotechnologyNorth AmericaPharmaceuticalResearchVaccines

Grifols acquires 51% stake in Araclon Biotech


Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Agenus expands deal with GlaxoSmithKline; Nuron in-licenses vaccines


US biotech firm Agenus (Nasdaq: AGEN) says it has amended the QS-21 license and manufacturing agreement…

AgenusAkshaya BioBiotechnologyGlaxoSmithKlineLicensingNuron BiotechPharmaceuticalVaccines



Back to top